Human Genome Sciences, Inc. - HGSI- Profile

Human Genome Sciences Inc. The Group's principal activities are to develop, manufacture and market protein and antibody drugs. The Group focuses on clinical trials in oncology, immunology and infectious diseases. The Clinical development include drugs to treat diseases like cancer, rheumatoid arthritis, lupus, hepatitis C, anthrax disease and HIV/AIDS. The Group focuses its internal product development efforts on novel human protein and antibody drugs discovered through genomics-based research and on new improved long-acting versions of existing protein drugs created using proprietary albumin fusion technology. The products of the Group include ABthrax, Albuferon, LymphoStat-B. Discovers, develops, manufactures and markets gene-based drugs to treat and cure disease